Loading…

Loading grant details…

Active HORIZON European Commission

Fighting Addictions, improving Lives: COmprehensive drug rehabilitation with music


Funder European Commission
Recipient Organization Norce Norwegian Research Centre As
Country Norway
Start Date Jan 01, 2025
End Date Dec 31, 2029
Duration 1,825 days
Number of Grantees 19
Roles Participant; Third Party; Associated Partner; Coordinator
Data Source European Commission
Grant ID 101155881
Grant Description

Objectives and ambition: Substance use disorder (SUD) is associated with a high global burden of disease, with 5.4% of all disability-adjusted life years lost due to alcohol and illicit drugs.

Highly prevalent multimorbidity includes polysubstance use, mental health conditions, and other non-communicable and infectious diseases.

Where traditional treatments are insufficient alone, music therapy (MT) is highly engaging and improves motivation and craving, but its long-term effects are unknown.Methodology: In a diverse group of people with SUD across a wide range of age, gender, socioeconomic, and cultural background, a parallel 3-arm assessor-blinded pragmatic multinational randomised clinical trial with embedded exploratory trials and mechanistic studies will determine long-term effects of active music groups (AMG) and music listening groups (MLG) versus treatment as usual (TAU) on addiction severity (primary: 1-year), recovery, and other health and socioeconomic outcomes.

Embedded trials will examine short-term effects of individual components of TAU combined with AMG or MLG to determine the best combinations of interventions. Experimental studies will examine mechanisms using neuropsychological tests and brain imaging. With 600 participants in 7 countries randomised, the trial has 80% power on the primary outcome.

Patient representatives, HTA bodies, and interventionists have been involved from conception and will ensure feasibility and applicability across Europe.Impact: FALCO will reduce disease burden through innovative, effective, and affordable treatment and will strengthen research and innovation expertise.

Recommendations from FALCO will inform intervention delivery across Europe and beyond, leading to increased safety, effectiveness and cost-effectiveness, and improved quality of life for people with SUD.

Stakeholders will be involved in communicating findings in all European countries and regions and ensuring that findings are effectively implemented.

All Grantees

Fundacio Institut D'Investigacio Biomedica de Girona Doctor Josep Trueta; Universitat de Girona; Universitat Wien; Hta Austria - Austrian Institute for Health Technology Assessment Gmbh; Fundació Sanitària D'Igualada; Universitat Fur Musik Und Darstellende Kunst Wien; Helse Stavanger Hf; Wojewodzki Osrodek Terapii Uzaleznien W Gdansku; Uniwersytet Gdanski; Bar Ilan University; Universita Degli Studi Di Pavia; Institucio Catalana de Recerca I Estudis Avancats Fundacio Privada; Universitat Zurich; Sykehuset Innlandet Hf; Stiftung Anton Proksch - Institut Wien; Fundacio Institut D'Investigacio Biomedica de Bellvitge; Norce Norwegian Research Centre As; Universitetet I Bergen; Herzog College

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant